Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viking Therapeutics (VKTX) Amortization of Deferred Charges (2019 - 2022)

Viking Therapeutics (VKTX) has disclosed Amortization of Deferred Charges for 4 consecutive years, with $77000.0 as the latest value for Q1 2022.

  • For Q1 2022, Amortization of Deferred Charges rose 6.94% year-over-year to $77000.0; the TTM value through Mar 2022 reached $301000.0, up 7.12%, while the annual FY2021 figure was $296000.0, 6.86% up from the prior year.
  • Amortization of Deferred Charges hit $77000.0 in Q1 2022 for Viking Therapeutics, up from $76000.0 in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $77000.0 in Q1 2022 and bottomed at $64000.0 in Q1 2019.
  • Average Amortization of Deferred Charges over 4 years is $70000.0, with a median of $70000.0 recorded in 2020.
  • Year-over-year, Amortization of Deferred Charges grew 7.58% in 2020 and then grew 5.88% in 2021.
  • Viking Therapeutics' Amortization of Deferred Charges stood at $66000.0 in 2019, then increased by 7.58% to $71000.0 in 2020, then increased by 7.04% to $76000.0 in 2021, then rose by 1.32% to $77000.0 in 2022.
  • According to Business Quant data, Amortization of Deferred Charges over the past three periods came in at $77000.0, $76000.0, and $75000.0 for Q1 2022, Q4 2021, and Q3 2021 respectively.